| Stem cell transplantation for light chain amyloidosis: decreased early mortality over time MH Sidiqi, MA Aljama, FK Buadi, RM Warsame, MQ Lacy, A Dispenzieri, ... Journal of Clinical Oncology 36 (13), 1323-1329, 2018 | 120 | 2018 |
| Two types of amyloidosis presenting in a single patient: a case series MH Sidiqi, ED McPhail, JD Theis, S Dasari, JA Vrana, ME Drosou, ... Blood cancer journal 9 (3), 30, 2019 | 58 | 2019 |
| Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis S Sidana, MH Sidiqi, A Dispenzieri, FK Buadi, MQ Lacy, E Muchtar, ... American journal of hematology 94 (9), 1020-1026, 2019 | 50 | 2019 |
| Venetoclax for the treatment of translocation (11; 14) AL amyloidosis MH Sidiqi, AS Al Saleh, N Leung, D Jevremovic, MA Aljama, ... Blood cancer journal 10 (5), 55, 2020 | 47 | 2020 |
| Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis S Sidana, E Muchtar, MH Sidiqi, D Jevremovic, A Dispenzieri, ... American journal of hematology 95 (5), 497-502, 2020 | 41 | 2020 |
| Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021 M Hasib Sidiqi, MA Gertz Blood cancer journal 11 (5), 90, 2021 | 40 | 2021 |
| Venetoclax for the treatment of multiple myeloma I Vaxman, MH Sidiqi, M Gertz Expert review of hematology 11 (12), 915-920, 2018 | 39 | 2018 |
| Daratumumab for the treatment of AL amyloidosis MH Sidiqi, MA Gertz Leukemia & lymphoma 60 (2), 295-301, 2019 | 32 | 2019 |
| Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma MA Aljama, MH Sidiqi, A Lakshman, A Dispenzieri, D Jevremovic, ... Blood Advances 2 (22), 3149-3154, 2018 | 29 | 2018 |
| Autologous stem cell transplant for IgM-associated amyloid light-chain amyloidosis MH Sidiqi, FK Buadi, A Dispenzieri, R Warsame, MQ Lacy, D Dingli, ... Biology of Blood and Marrow Transplantation 25 (3), e108-e111, 2019 | 26 | 2019 |
| Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation MH Sidiqi, MA Aljama, E Muchtar, FK Buadi, R Warsame, MQ Lacy, ... Blood Advances 2 (7), 769-776, 2018 | 25 | 2018 |
| Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials MH Sidiqi, AS Al Saleh, SK Kumar, N Leung, D Jevremovic, E Muchtar, ... American journal of hematology 96 (9), 1131-1136, 2021 | 24 | 2021 |
| Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients AS Al Saleh, MH Sidiqi, A Dispenzieri, P Kapoor, E Muchtar, FK Buadi, ... American journal of hematology 95 (1), 4-9, 2020 | 24 | 2020 |
| Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma MH Sidiqi, MA Aljama, I Bin Riaz, A Dispenzieri, E Muchtar, FK Buadi, ... Blood cancer journal 8 (11), 106, 2018 | 24 | 2018 |
| The human microbiota in multiple myeloma and proteasome inhibitors O Alkharabsheh, MH Sidiqi, MA Aljama, MA Gertz, AE Frankel Acta Haematologica 143 (2), 118-123, 2020 | 22 | 2020 |
| Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis MH Sidiqi, S Dasari, ED McPhail, FK Buadi, R Warsame, MQ Lacy, ... American journal of hematology 94 (5), E141-E143, 2019 | 22 | 2019 |
| Utility and prognostic value of 18F‐FDG positron emission tomography‐computed tomography scans in patients with newly diagnosed multiple myeloma MA Aljama, MH Sidiqi, FK Buadi, MQ Lacy, MA Gertz, A Dispenzieri, ... American journal of hematology 93 (12), 1518-1523, 2018 | 21 | 2018 |
| Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis AS Al Saleh, MH Sidiqi, S Sidana, E Muchtar, A Dispenzieri, D Dingli, ... American journal of hematology 94 (10), 1066-1071, 2019 | 20 | 2019 |
| Prognostic significance of stringent complete response after stem cell transplantation in immunoglobulin light chain amyloidosis MH Sidiqi, MA Aljama, D Jevremovic, E Muchtar, FK Buadi, R Warsame, ... Biology of Blood and Marrow Transplantation 24 (11), 2360-2364, 2018 | 19 | 2018 |
| Autologous stem cell transplant for immunoglobulin light chain amyloidosis patients aged 70 to 75 MH Sidiqi, MA Aljama, E Muchtar, FK Buadi, R Warsame, MQ Lacy, ... Biology of Blood and Marrow Transplantation 24 (10), 2157-2159, 2018 | 17* | 2018 |
